Form 4 for NAMS NewAmsterdam Pharma Co N.V.
Accepted 2026-09-03 16:30:05 ET · period of report 2026-09-01 · accession 0001193125-26-381953 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-03 16:30 | 2026-09-01 | NAMS | Gunning Robert William | VP, Ctrl | A - Grant | $0.00 | +3,200 | 3,200 | New | $0 |
| D | 2026-09-03 16:30 | 2026-09-01 | NAMS | Gunning Robert William | VP, Ctrl | A - Grant | $0.00 | +14.0K | 14.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-09-01 | A | A | 3,200 | $0.00 | 3,200 | D | — | — | (F1) Represents restricted stock units ("RSUs"), each representing a contingent right to receive one ordinary share. 1/3 of the RSUs will vest on each of the first, second and third anniversaries of the vesting start date, September 10, 2026, subject to the Reporting Person's continued service through each such date. |
| 2 | Derivative | Option (right to buy) | 2026-09-01 | A | A | 14,000 | $0.00 | 14,000 | D | $24.92 · — to 2036-08-31 | 14,000 Ordinary Shares | (F2) 25% of the shares underlying the option will vest on August 10, 2026, the one-year anniversay of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date. |